Svanborg, Kerstin Dybrandt

1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial

Kakko, J., Svanborg, K. D., Kreek, M. J., & Heilig, M. (2003) · The Lancet

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 466

Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence

Kakko, J., von Wachenfeldt, J., Svanborg, K. D., Lidström, J., Barr, C. S., & Heilig, M. (2008) · Biological Psychiatry

Opioid Use Disorder TreatmentStress Responses and Cortisol

Cited by 41